Obesity increases the risk of postmenopausal breast cancer and is associated with more advanced stage at presentation but no impact on survival

Breast Journal

Volumn 16, Issue 1, 2010, Pages 95-97

  Healy, Laura A ^a   Ryan, Aoife M ^a   Rowley, Suzanne ^a   Boyle, Terry ^a   Connolly, Elizabeth ^a   Kennedy, Michael J ^a   Reynolds, John V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; LETTER; OBESITY; POSTMENOPAUSE;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; IRELAND; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OBESITY; ODDS RATIO; POSTMENOPAUSE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 77249154678     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00861.x     Document Type: Letter

References (19)

1. National Cancer Registry Ireland. All Ireland cancer statistics report 1998-2000, National Cancer Registry Ireland. Available at: http://www.ncri.ie. (last accessed on 25 July 2008)
2. National Cancer Registry Ireland. Women and cancer in Ireland 1994-2001, National Cancer Registry Ireland. Available at: http://www.ncri.ie. (last accessed on 25 July 2008)
3. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43.
4. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ 2007;335:1134.
5. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 2003;106:96-102.
6. Thomas HV, Reeves GK, Key TJA. Endogenous estrogen and postmenopausal breast cancer: a quantitive review. Cancer Causes Control 1997;8:922-8.
7. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
8. Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European Perspective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82.
9. Cowet S, Hardy RW. The metabolic syndrome. A high risk state for cancer? Am J Path 2006;169:1505-22.
10. Laud K, Gourdou I, Pessemesse L, et al. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002;188:219- 26.
11. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004;10:4325-31.
12. Miyoshi Y, Funahasi T, Tanaka S, et al. High expression of leptin receptor m RNA in breast cancer tissue predicts poor prognosis for patients with high but not low serum leptin levels. Int J Cancer 2006;118:1414-9.
13. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001;92:720-9.
14. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
15. Lahmann PH, Lissner L, Berglund G. Breast cancer risk in overweight postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004;13:1414.
16. Li CI, Malone KE, Daling JR. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States). Cancer Causes Control 2006;17:695-703.
17. Majed B, Moreau T, Senouci K, et al. Is obesity an independent prognosis factor in woman breast cancer. Breast Cancer Res Treat 2008;111:329-42.
18. Fowable BL, Schultz DJ, Overmore B, et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994;30:23-33.
19. Elkum N, Dermine S, Ajarim D, et al. Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer 2007;5:222.